"The Good, the Bad and the Ugly": Interplay of Innate Immunity and Inflammation

被引:1
作者
Aleman, Mercedes [1 ]
机构
[1] Acad Nacl Med Buenos Aires, Lab Inmunol Expt, Inst Med Expt IMEX, CONTICET, Buenos Aires, DF, Argentina
关键词
RESPIRATORY SYNCYTIAL VIRUS; GLUCAN RECEPTOR DECTIN-1; MYCOBACTERIUM-TUBERCULOSIS; RIG-I; PATHOGEN RECOGNITION; BCG VACCINATION; GUINEA-BISSAU; INFECTION; MACROPHAGE; HOST;
D O I
10.1155/2022/2759513
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Innate immunity recognizes microorganisms through certain invariant receptors named pattern recognition receptors (PRRs) by sensing conserved pathogen-associated molecular patterns (PAMPs). Their recognition activates several signaling pathways that lead the transcription of inflammatory mediators, contributing to trigger a very rapid inflammatory cascade aiming to contain the local infection as well as activating and instructing the adaptive immunity in a specific and synchronized immune response according to the microorganism. Inflammation is a coordinated process involving the secretion of cytokines and chemokines by macrophages and neutrophils leading to the migration of other leukocytes along the endothelium into the injured tissue. Sustained inflammatory responses can cause deleterious effects by promoting the development of autoimmune disorders, allergies, cancer, and other immune pathologies, while weak signals could exacerbate the severity of the disease. Therefore, PRR-mediated signal transduction must be tightly regulated to maintain host immune homeostasis. Innate immunity deficiencies and strategies deployed by microbes to avoid inflammatory responses lead to an altered immune response that allows the pathogen to proliferate causing death or uncontrolled inflammation. This review analyzes the complexity of the immune response at the beginning of the disease focusing on COVID-19 disease and the importance of unraveling its mechanisms to be considered when treating diseases and designing vaccines.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Chemokines in tuberculosis: The good, the bad and the ugly
    Monin, Leticia
    Khader, Shabaana A.
    SEMINARS IN IMMUNOLOGY, 2014, 26 (06) : 552 - 558
  • [2] RIPK3 in cell death and inflammation: the good, the bad, and the ugly
    Orozco, Susana
    Oberst, Andrew
    IMMUNOLOGICAL REVIEWS, 2017, 277 (01) : 102 - 112
  • [3] Actinobacteria: the good, the bad, and the ugly
    Miao, Vivian
    Davies, Julian
    ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, 2010, 98 (02): : 143 - 150
  • [4] Editorial: Parasitism: the good, the bad and the ugly
    Juarez-Estrada, Marco A.
    Graham, Danielle
    Hernandez-Velasco, Xochitl
    Tellez-Isaias, Guillermo
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [5] Monoclonal gammopathy: The good, the bad and the ugly
    Glavey, Siobhan V.
    Leung, Nelson
    BLOOD REVIEWS, 2016, 30 (03) : 223 - 231
  • [6] Neutrophils in malaria: The good, the bad or the ugly?
    Pollenus, Emilie
    Gouwy, Mieke
    Van den Steen, Philippe E.
    PARASITE IMMUNOLOGY, 2022, 44 (06)
  • [8] When good turns bad: how viruses exploit innate immunity factors
    Bozzo, Caterina Prelli
    Kmiec, Dorota
    Kirchhoff, Frank
    CURRENT OPINION IN VIROLOGY, 2022, 52 : 60 - 67
  • [9] Response to Dengue Fever -- The Good, the Bad, and the Ugly?.
    Schmidt, Alexander C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (05) : 484 - 487
  • [10] The role of lncRNAs in innate immunity and inflammation
    Walther, Katharina
    Schulte, Leon N.
    RNA BIOLOGY, 2021, 18 (05) : 587 - 603